In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Apellis Pharmaceuticals Inc (NASDAQ: APLS) was $34.14 for the day, up 4.63% from the previous closing price of $32.63. In other words, the price has increased by $4.63 from its previous closing price. On the day, 2.04 million shares were traded. APLS stock price reached its highest trading level at $34.4 during the session, while it also had its lowest trading level at $32.77.
Ratios:
Our analysis of APLS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.73 and its Current Ratio is at 4.36. In the meantime, Its Debt-to-Equity ratio is 1.98 whereas as Long-Term Debt/Eq ratio is at 1.96.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on November 21, 2024, initiated with a Equal-Weight rating and assigned the stock a target price of $31.
On October 25, 2024, RBC Capital Mkts started tracking the stock assigning a Sector Perform rating and target price of $25.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 16 ’24 when Dunlop A. Sinclair sold 37,000 shares for $36.23 per share. The transaction valued at 1,340,597 led to the insider holds 100,000 shares of the business.
Chopas James George sold 192 shares of APLS for $6,952 on Sep 16 ’24. The VP/Chief Accounting Officer now owns 38,141 shares after completing the transaction at $36.21 per share. On Sep 16 ’24, another insider, Chopas James George, who serves as the Officer of the company, bought 192 shares for $36.21 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLS now has a Market Capitalization of 4246776832 and an Enterprise Value of 4313537536. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.21 while its Price-to-Book (P/B) ratio in mrq is 17.58. Its current Enterprise Value per Revenue stands at 6.031 whereas that against EBITDA is -19.474.
Stock Price History:
Over the past 52 weeks, APLS has reached a high of $73.80, while it has fallen to a 52-week low of $24.34. The 50-Day Moving Average of the stock is 18.80%, while the 200-Day Moving Average is calculated to be -18.02%.
Shares Statistics:
APLS traded an average of 3.03M shares per day over the past three months and 5058920 shares per day over the past ten days. A total of 119.56M shares are outstanding, with a floating share count of 100.96M. Insiders hold about 18.84% of the company’s shares, while institutions hold 92.74% stake in the company. Shares short for APLS as of 1731628800 were 23182889 with a Short Ratio of 7.65, compared to 1728950400 on 21088064. Therefore, it implies a Short% of Shares Outstanding of 23182889 and a Short% of Float of 25.52.
